Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caffeine Reduces Acute Ischemic Preconditioning

NCT00184912 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00184912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00184912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caffeine Reduces Acute Ischemic Preconditioning
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2003
Completion date
January 31, 2006
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caffeine, ischemia-reperfusion injury, ischemic preconditioning